Out of concern for the spread of Corona (COVID-19) virus, and out of an abundance of caution, the March 26 IALSN general meeting is cancelled. Our most sincere apologies to our speaker and all of you for any inconvenience. We look forward to rescheduling this event at a later date.
Best wishes to all of you
“Gut microbiome - moving from association to causation and therapy”
By: Dr. Bernd Schnabl, MD, Professor of Medicine in Gastroenterology at UCSD School of Medicine
Dr. Schnabl received his MD degree from the University Freiburg in Germany and completed a gastroenterology fellowship at Columbia University. He is Professor of Medicine in the Division of Gastroenterology at UCSD. He is also staff physician and attending at the VA San Diego Medical Center in La Jolla and the UCSD Medical Center. As a physician scientist, he is interested in learning about the contribution of the gut microbiome to the onset and progression of liver diseases. Using system biology approaches, his lab is trying to better understand the interaction between the intestinal microbiome and the liver during chronic liver disease.
Dr. Schnabl has published extensively in highly-regarded journals and has authored multiple reviews and book chapters. He is the principal investigator of a VA Merit Award, several NIH, foundation and industry-sponsored grants. Dr. Schnabl served as Associate Editor for Digestive Diseases and Sciences, which is the oldest continuously published GI journal in North America. He is also the Director of the NIH-funded San Diego Digestive Disease Research Center.
March, 26, 2020
6:00 - 8:00 pm.
10300 Campus Point Dr.
San Diego, CA, 92121
1st. Floor Conference Room
Due to the Coronavirus (COVID- 19) the Spring Dinner Gala will be changed to Summer Dinner Gala. Further information will be shared with you in due time.
IALSN Annual Membership is $75
$75 Membership provides the following:
Two Tickets for Spring Gala including dinner, wine, desserts and entertainment plus two Additional Complimentary Admission Tickets for member’s guests
4 quarterly meetings, including dinner and drinks, featuring Scientific presentation by renowned local scientist
Opportunity to network with other members
Access to our website for job postings
Dr. Paul Grint
Chief Executives Officer of the AmpliPhi Biosciences, Inc
President and Chief Executive Officer of Arcturus Therapeutics Ltd
John M. Beals, Ph.D.
Dr. Hakan Sakul
VP and the head of Diagnostics Worldwide Research
Mauro Mileni, CEO
Founder of Abilita Bio, Inc
Dr. Alan LGaveck
Podiatric foot and ankle surgeon
Peter C. Farrell
PhD, DSc, AM, Founder and Chairman of the board, ResMed